WO2010090502A3 - Composition de préparation externe contenant du cholécalciférol ou un dérivé de celui-ci pour traiter des troubles cutanés - Google Patents
Composition de préparation externe contenant du cholécalciférol ou un dérivé de celui-ci pour traiter des troubles cutanés Download PDFInfo
- Publication number
- WO2010090502A3 WO2010090502A3 PCT/KR2010/000808 KR2010000808W WO2010090502A3 WO 2010090502 A3 WO2010090502 A3 WO 2010090502A3 KR 2010000808 W KR2010000808 W KR 2010000808W WO 2010090502 A3 WO2010090502 A3 WO 2010090502A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- derivative
- skin disorders
- treating skin
- composition containing
- external use
- Prior art date
Links
- 239000011647 vitamin D3 Substances 0.000 title abstract 4
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 title abstract 4
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 title abstract 3
- 208000017520 skin disease Diseases 0.000 title abstract 3
- 235000005282 vitamin D3 Nutrition 0.000 title abstract 3
- 229940021056 vitamin d3 Drugs 0.000 title abstract 3
- 230000000857 drug effect Effects 0.000 abstract 2
- 239000002502 liposome Substances 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 230000035515 penetration Effects 0.000 abstract 2
- 206010012438 Dermatitis atopic Diseases 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 201000008937 atopic dermatitis Diseases 0.000 abstract 1
- 230000003902 lesion Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82B—NANOSTRUCTURES FORMED BY MANIPULATION OF INDIVIDUAL ATOMS, MOLECULES, OR LIMITED COLLECTIONS OF ATOMS OR MOLECULES AS DISCRETE UNITS; MANUFACTURE OR TREATMENT THEREOF
- B82B3/00—Manufacture or treatment of nanostructures by manipulation of individual atoms or molecules, or limited collections of atoms or molecules as discrete units
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01L—SEMICONDUCTOR DEVICES NOT COVERED BY CLASS H10
- H01L21/00—Processes or apparatus adapted for the manufacture or treatment of semiconductor or solid state devices or of parts thereof
- H01L21/02—Manufacture or treatment of semiconductor devices or of parts thereof
- H01L21/04—Manufacture or treatment of semiconductor devices or of parts thereof the devices having potential barriers, e.g. a PN junction, depletion layer or carrier concentration layer
- H01L21/18—Manufacture or treatment of semiconductor devices or of parts thereof the devices having potential barriers, e.g. a PN junction, depletion layer or carrier concentration layer the devices having semiconductor bodies comprising elements of Group IV of the Periodic Table or AIIIBV compounds with or without impurities, e.g. doping materials
- H01L21/20—Deposition of semiconductor materials on a substrate, e.g. epitaxial growth solid phase epitaxy
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Nanotechnology (AREA)
- Manufacturing & Machinery (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dispersion Chemistry (AREA)
- Physics & Mathematics (AREA)
- Condensed Matter Physics & Semiconductors (AREA)
- General Physics & Mathematics (AREA)
- Computer Hardware Design (AREA)
- Microelectronics & Electronic Packaging (AREA)
- Power Engineering (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
Abstract
La présente invention concerne une composition de préparation externe contenant du cholécalciférol ou un dérivé de celui-ci pour traiter des troubles cutanés. Plus spécifiquement, la présente invention concerne une composition de préparation externe pour traiter des troubles cutanés tels que la dermite atopique et un procédé pour fabriquer un liposome. La composition et le procédé augmentent la pénétration dans la peau en encapsulant le cholécalciférol (vitamine D3) ou un dérivé de celui-ci en tant que substance active dans un liposome nanoscopique de sorte que le temps de pénétration dans la peau puisse être réduit au minimum lorsqu'il est appliqué sur une lésion. Par conséquent, des variations des effets pharmaceutiques par la lumière sont réduites et les effets pharmaceutiques sont rapidement exprimés.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2009-0010324 | 2009-02-09 | ||
KR1020090010324A KR101147600B1 (ko) | 2009-02-09 | 2009-02-09 | 콜레칼시페롤 또는 이의 유도체를 함유하는 피부질환 치료용 외용제 조성물 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2010090502A2 WO2010090502A2 (fr) | 2010-08-12 |
WO2010090502A3 true WO2010090502A3 (fr) | 2011-01-20 |
Family
ID=42542544
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2010/000808 WO2010090502A2 (fr) | 2009-02-09 | 2010-02-09 | Composition de préparation externe contenant du cholécalciférol ou un dérivé de celui-ci pour traiter des troubles cutanés |
Country Status (2)
Country | Link |
---|---|
KR (1) | KR101147600B1 (fr) |
WO (1) | WO2010090502A2 (fr) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111494321A (zh) * | 2020-04-28 | 2020-08-07 | 南通华山药业有限公司 | 一种骨化三醇长循环脂质体及其制备方法 |
IT202200000629A1 (it) * | 2022-01-17 | 2023-07-17 | Fondazione St Italiano Tecnologia | Nanocluster vitaminici come veicolanti e agenti terapeutici e nutraceutici |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5834016A (en) * | 1996-04-04 | 1998-11-10 | Cilag Ag | Liposome-based topical vitamin D formulation |
EP0998925A1 (fr) * | 1997-05-26 | 2000-05-10 | New Vision Co., Ltd. | Compositions medicinales a administration topique renfermant les vitamines d et les vitamines k |
US20050026877A1 (en) * | 2002-12-03 | 2005-02-03 | Novacea, Inc. | Pharmaceutical compositions comprising active vitamin D compounds |
US20070110685A1 (en) * | 2005-06-17 | 2007-05-17 | Auspitz Benjamin A | Combination therapy for the treatment of immunoinflammatory disorders |
US20080280860A1 (en) * | 2005-03-23 | 2008-11-13 | Bioxell S.P.A. | Use of Vitamin D Compounds to Treat Endometriosis |
-
2009
- 2009-02-09 KR KR1020090010324A patent/KR101147600B1/ko not_active IP Right Cessation
-
2010
- 2010-02-09 WO PCT/KR2010/000808 patent/WO2010090502A2/fr active Application Filing
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5834016A (en) * | 1996-04-04 | 1998-11-10 | Cilag Ag | Liposome-based topical vitamin D formulation |
EP0998925A1 (fr) * | 1997-05-26 | 2000-05-10 | New Vision Co., Ltd. | Compositions medicinales a administration topique renfermant les vitamines d et les vitamines k |
US20050026877A1 (en) * | 2002-12-03 | 2005-02-03 | Novacea, Inc. | Pharmaceutical compositions comprising active vitamin D compounds |
US20080280860A1 (en) * | 2005-03-23 | 2008-11-13 | Bioxell S.P.A. | Use of Vitamin D Compounds to Treat Endometriosis |
US20070110685A1 (en) * | 2005-06-17 | 2007-05-17 | Auspitz Benjamin A | Combination therapy for the treatment of immunoinflammatory disorders |
Also Published As
Publication number | Publication date |
---|---|
KR20100091048A (ko) | 2010-08-18 |
WO2010090502A2 (fr) | 2010-08-12 |
KR101147600B1 (ko) | 2012-05-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2014188276A3 (fr) | Compositions d'antioxydants et procédés d'utilisation | |
WO2009047644A3 (fr) | Procédé de traitement d'une insuffisance et d'une carence en vitamine d | |
WO2010000877A3 (fr) | Formulation à base de bisabolol et de [6]-paradol produisant un effet apaisant sur les irritations | |
WO2014138471A3 (fr) | Composés résorcinols pour un usage dermatologique | |
WO2009147402A3 (fr) | Compositions | |
AU2014359194A1 (en) | Lipid microcapsules preferably comprising a retinoid, and composition containing same, method for the production thereof, and use thereof in dermatology | |
WO2006120682A3 (fr) | Compositions et methodes pour traiter des maladies epidermiques hyperproliferatives | |
WO2008048963A3 (fr) | Compositions naturelles pour tuer des parasites sur un animal de compagnie | |
WO2011130302A3 (fr) | Procédés de traitement de l'obésité utilisant des modulateurs d'inflammation antioxydants | |
WO2010027792A8 (fr) | Traitement de la transpiration et de l'hyperhidrose | |
WO2009105294A3 (fr) | Compositions topiques et procédés pour le blanchiment de la peau | |
WO2007096601A3 (fr) | Formules | |
WO2011090270A3 (fr) | Composition contenant de l'osmotine pour prévenir et traiter des troubles neurologiques | |
WO2006120681A3 (fr) | Compositions et procedes de soin de la peau | |
WO2013178965A3 (fr) | Principes actifs activateurs de la mitophagie des cellules cutanées et utilisation pour améliorer l'état de la peau | |
WO2011049327A3 (fr) | Composition de soin externe pour la peau comprenant un sel et du sucre en tant que principes actifs pour prévenir et traiter la vaginose et utilisation de cette composition | |
EP3067059A4 (fr) | Composition pharmaceutique pour prévenir ou traiter des maladies thyroïdiennes, contenant de l'extrait de fruit de lonicera caerulea l. var. edulis comme principe actif | |
WO2011042902A3 (fr) | Microcapsules comprenant du peroxyde de benzoyle et compositions topiques comprenant celles-ci | |
WO2012050745A3 (fr) | Compositions contenant du zinc pca et un extrait d'anogeissus | |
WO2009118726A3 (fr) | Combinaison orale de vitamines | |
WO2012002730A3 (fr) | Composition hydratante et de blanchiment de la peau contenant des extraits de venin d'abeille | |
IN2014DE01913A (fr) | ||
WO2005004891A3 (fr) | Utilisation d’un antioxydant dans une composition a usage dermatologique et/ou cosmetique | |
WO2014041528A3 (fr) | Composition | |
EP3352750A4 (fr) | Dérivé de cyclohexène, son procédé de préparation et composition pharmaceutique pour prévenir ou traiter une maladie métabolique, contenant ledit dérivé comme principe actif |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 10738786 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 10738786 Country of ref document: EP Kind code of ref document: A2 |